Loading clinical trials...

Coronary Artery Stent Evaluation With 320-slice Computed Tomography - The CArS 320 Study | Clinical Trials | Clareo Health

COMPLETED

Coronary Artery Stent Evaluation With 320-slice Computed Tomography - The CArS 320 Study

NCT00967876•Charite University, Berlin, Germany

View on ClinicalTrials.gov

Summary

The investigators aim at analyzing the diagnostic accuracy of 320-row CT for coronary stents.

Eligibility

Age

40 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Suspected coronary artery in-stent restenoses based on clinical findings or findings on other noninvasive imaging tests and planned coronary angiography within the next 14 days.
•Able to understand and willing to sign the Informed CF.

Exclusion Criteria

•Creatinine of above 2.0 mg/dl
•Age below 40 years
•Women of child bearing potential (no hysterectomy, no menopause, or menopause since less than 12 months) must demonstrate a negative pregnancy test performed within 24 hours before CT.
•Resting heart rate above 70 beats per minute and contraindications to beta blockers (e.g. moderate to severe bronchospastic disease, asthma)
•Atrial fibrillation, uncontrolled tachycardia, A-V block II or III degree or other non-sinus rhythms
•Inability to hold the breath for 10 seconds
•Hypotension \< 80 mmHg systolic
•Unstable angina pectoris, acute myocardial infarction \< 48h
•Continuous therapy with Dipyridamol
•Severe aortic stenosis

Locations (1)

Charité

Berlin, State of Berlin, Germany

Key Dates

Start Date

April 1, 2009

Primary Completion Date

November 1, 2011

Last Updated

July 23, 2014

Enrollment

ESTIMATED participants

Conditions

Coronary Artery Stenosis

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

NCT05831085

Coronary Artery Stenosis

View study

RECRUITING

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

NCT05860400

Coronary Artery DiseaseCoronary Artery Stenosis+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 23, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Coronary Artery Stent Evaluation With 320-slice Computed Tomography - The CArS 320 Study

Inclusion Criteria

Exclusion Criteria

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR

The OPTIMAL Randomized Controlled Trial

Anthocyanin Intake on Cardiometabolic Biomarkers

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon